HBIO vs JD · rev $22.7M vs P/E 7.6, rev $187.20B
Harvard Bioscience Inc (HBIO) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
HBIO currently screens at market cap $20.3M. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the HBIO and JD stock pages for the full models.
Not investment advice.